168 related articles for article (PubMed ID: 32598439)
21. microRNA-mRNA Networks Linked to Inflammation and Immune System Regulation in Inflammatory Bowel Disease.
Síbia CF; Quaglio AEV; Oliveira ECS; Pereira JN; Ariede JR; Lapa RML; Severino FE; Reis PP; Sassaki LY; Saad-Hossne R
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38398024
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
[TBL] [Abstract][Full Text] [Related]
23. Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.
Lin J; Welker NC; Zhao Z; Li Y; Zhang J; Reuss SA; Zhang X; Lee H; Liu Y; Bronner MP
Mod Pathol; 2014 Apr; 27(4):602-8. PubMed ID: 24051693
[TBL] [Abstract][Full Text] [Related]
24. Divergent influence of microRNA-21 deletion on murine colitis phenotypes.
Wu F; Dong F; Arendovich N; Zhang J; Huang Y; Kwon JH
Inflamm Bowel Dis; 2014 Nov; 20(11):1972-85. PubMed ID: 25222661
[TBL] [Abstract][Full Text] [Related]
25. Redefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases.
Ostrowski J; Dabrowska M; Lazowska I; Paziewska A; Balabas A; Kluska A; Kulecka M; Karczmarski J; Ambrozkiewicz F; Piatkowska M; Goryca K; Zeber-Lubecka N; Kierkus J; Socha P; Lodyga M; Klopocka M; Iwanczak B; Bak-Drabik K; Walkowiak J; Radwan P; Grzybowska-Chlebowczyk U; Korczowski B; Starzynska T; Mikula M
J Crohns Colitis; 2019 Apr; 13(5):626-633. PubMed ID: 30541017
[TBL] [Abstract][Full Text] [Related]
26. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4
Nie J; Zhao Q
Front Immunol; 2020; 11():852. PubMed ID: 32547537
[No Abstract] [Full Text] [Related]
27. Circulating miR-199a and long noncoding-RNA ANRIL as Promising Diagnostic Biomarkers for Inflammatory Bowel Disease.
Erfan R; Shaker OG; Khalil MAF; Mahmoud FAM; Gomaa MS; Abu-El-Azayem AK; Zaki OM; Ahmed AM; Samy A; Mohammed A
Inflamm Bowel Dis; 2024 Jan; ():. PubMed ID: 38190238
[TBL] [Abstract][Full Text] [Related]
28. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease.
Wu F; Guo NJ; Tian H; Marohn M; Gearhart S; Bayless TM; Brant SR; Kwon JH
Inflamm Bowel Dis; 2011 Jan; 17(1):241-50. PubMed ID: 20812331
[TBL] [Abstract][Full Text] [Related]
29. Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease.
Batra SK; Heier CR; Diaz-Calderon L; Tully CB; Fiorillo AA; van den Anker J; Conklin LS
Inflamm Bowel Dis; 2020 Sep; 26(10):1597-1606. PubMed ID: 32793975
[TBL] [Abstract][Full Text] [Related]
30. Role of miR-22 in intestinal mucosa tissues and peripheral blood CD4+ T cells of inflammatory bowel disease.
Pei XF; Cao LL; Huang F; Qiao X; Yu J; Ye H; Xi CL; Zhou QC; Zhang GF; Gong ZL
Pathol Res Pract; 2018 Aug; 214(8):1095-1104. PubMed ID: 29880327
[TBL] [Abstract][Full Text] [Related]
31. A blood-based prognostic biomarker in IBD.
Biasci D; Lee JC; Noor NM; Pombal DR; Hou M; Lewis N; Ahmad T; Hart A; Parkes M; McKinney EF; Lyons PA; Smith KGC
Gut; 2019 Aug; 68(8):1386-1395. PubMed ID: 31030191
[TBL] [Abstract][Full Text] [Related]
32. [Expression of elafin in peripheral blood in inflammatory bowel disease patients and its clinical significance].
Zhang W; Teng GG; Tian Y; Wang HH
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1120-3. PubMed ID: 27095781
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.
James JP; Riis LB; Malham M; Høgdall E; Langholz E; Nielsen BS
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114313
[TBL] [Abstract][Full Text] [Related]
34. [Expression of microRNA-155 in inflammatory bowel disease and its clinical significance].
Ye YL; Pang Z; Gu W; Zheng JJ
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3716-3719. PubMed ID: 29325325
[No Abstract] [Full Text] [Related]
35. Circulating microRNAs as biomarkers of adult Crohn's disease.
Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
[TBL] [Abstract][Full Text] [Related]
36. Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease.
Wang H; Zhang S; Yu Q; Yang G; Guo J; Li M; Zeng Z; He Y; Chen B; Chen M
Medicine (Baltimore); 2016 Feb; 95(5):e2703. PubMed ID: 26844512
[TBL] [Abstract][Full Text] [Related]
37. Identification of microRNAs associated with ileal and colonic Crohn's disease.
Wu F; Zhang S; Dassopoulos T; Harris ML; Bayless TM; Meltzer SJ; Brant SR; Kwon JH
Inflamm Bowel Dis; 2010 Oct; 16(10):1729-38. PubMed ID: 20848482
[TBL] [Abstract][Full Text] [Related]
38. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease.
Shaker OG; Safa A; Khairy A; Abozeid NF
Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920
[TBL] [Abstract][Full Text] [Related]
39. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
[TBL] [Abstract][Full Text] [Related]
40. Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.
Gracie DJ; Guthrie EA; Hamlin PJ; Ford AC
Gastroenterology; 2018 May; 154(6):1635-1646.e3. PubMed ID: 29366841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
